Social Media Wiki

What If Your Customers Could Vote on Your Ads?

For avid Facebook users, you’ve all noticed the ads that are stuck onto the right side of your screen on nearly every page.

What?

You haven’t noticed them? Well, they are there. Go check it out for yourself and come back.

See. I told you they were there. Don’t feel bad if you didn’t notice them. You’re in good company. Most people don’t notice them. Like many forms of banner ads, they are simply ignored and since they are relatively new to Facebook and people are very focused while on the site, this is even more true. Of course, you may have checked and found that there are no ads on Facebook for you. Congratulations. You’re in good company again along with the millions who use browser plugins to disable all of these ads (myself included).

Monitoring Adverse Events in Social Media for Pharma’s Biggest Brands: Hopeless Task or Simple Project?

Dose of Digital Mini White Paper

Hopeless Task?

Today’s post was co-written with Melissa Davies, Healthcare Research Director at Nielsen in the Online Division.

Key Points Summary (detailed post follows)

  • Reportable adverse events are far less common than most people suspect. There are only approximately 166 reportable adverse events per day recorded across the entire pharma industry.
  • Even for the biggest pharma brands, there are very few discussion happening online that include a mention about the brand. Only 36 per day for the biggest selling drug in the world, Lipitor.

8 Tips to Help You Own YouTube’s Search Results

Dose of Digital Mini White Paper

I’ve talked a lot about search engine marketing (both paid and organic) on this blog (check out all of my posts on this topic here , here and here) and yet, as I continue to attend conferences, I don’t hear anything about the giant opportunity search could be for every pharma and healthcare company. This giant opportunity exists because very few of the industry’s websites are actually optimized for search. What this means is that they aren’t owing, or even showing up, for critical keywords. Here’s how Lipitor, the top-selling drug in the world, does for search. If you want all the details on this table, click here. The numbers represent what position Lipitor.com shows up in search results for various keywords. A dash indicates that Lipitor.com is not in the top 500 results for the keyword (note: this was conducted in May).

Pharma Should Forget About Social Media Monitoring

Dose of Digital Mini White Paper

That Sham Wow Guy

<Play along and use your best infomercial voice to read this first paragraph.>

Do you find yourself frustrated that you can’t take action when you see something bad said about your product on Facebook? Do you find yourself secretly logging in at home to see what bloggers are saying about you? Do you fret that bad things are being said about your brand on WebMD, but you can’t go and check? Do you have a passing interest in Twitter, but don’t want to spend hours figuring out how it works? Well, then social media monitoring is NOT for you!

Pharma and Healthcare Social Media Wiki Updates (and Badges!)

The updates continue on the Pharma and Healthcare Social Media Wiki. I’ve added about 20 more listings today, which brings the total pretty close to 400 examples of pharma and healthcare social media programs. Thanks to everyone who continues to send recommendations for sites and programs to include in the wiki.

Many of you have asked what you can do to support the wiki, as you’ve found it so useful. Well, there are a few things you can do since you asked:

6 Steps to Getting Your Healthcare Social Media Idea Approved

Dose of Digital Mini White Paper

Ready for this revelation? The healthcare industry, particularly pharma, is heavily regulated. I know, a shock to all of you. You also probably have heard that every company in this industry has a team of lawyers and regulatory folks whose sole responsibility is to ensure that the company isn’t getting into trouble with regulators. Many of these internal folks are charged specifically with making sure marketing teams aren’t putting the company at risk with a program that violates regulations. As a former pharma marketer, I know these folks have prevented me from getting into what likely would have been some pretty hot water over the years. That’s what they do. However, in some cases, marketers view these internal groups as another obstacle to getting their program into the market. I’m sure that at some companies this is truly the case. I don’t have a lot of advice for you if this is your situation.

Greetings from the Business Development Institute Conference

Yesterday, I had the chance to speak at the Business Development Institute’s Social Communications & Healthcare Case Studies and Roundtables Conference. It was a well-done conference with about 350 people in attendance, which is a pretty big number these days. I also got to meet in person some of my Twitter friends, which was great.

Speaking of Twitter, there was quite a bit of participation during the conference and you can run through the entire stream. You can search for #bdi or review it all in real time here.

Older Posts »